- call +1-201-465-4211
- email sales@mrinsights.biz
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
Scope of the Report:
This report studies the NGS Based Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the NGS Based Diagnostics market by product type and applications/end industries.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
The global NGS Based Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of NGS Based Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
Market Segment by Applications, can be divided into
Hospitals
Clinics
Academics/Research Institutions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 NGS Based Diagnostics Market Overview
1.1 Product Overview and Scope of NGS Based Diagnostics
1.2 Classification of NGS Based Diagnostics by Types
1.2.1 Global NGS Based Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global NGS Based Diagnostics Revenue Market Share by Types in 2017
1.2.3 DNA Sequencing
1.2.4 RNA Sequencing
1.2.5 Whole Genome Sequencing
1.2.6 Whole Exome Sequencing
1.2.7 Other
1.3 Global NGS Based Diagnostics Market by Application
1.3.1 Global NGS Based Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academics/Research Institutions
1.4 Global NGS Based Diagnostics Market by Regions
1.4.1 Global NGS Based Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) NGS Based Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) NGS Based Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NGS Based Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) NGS Based Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NGS Based Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of NGS Based Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Janssen
2.1.1 Business Overview
2.1.2 NGS Based Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Janssen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 NGS Based Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Qiagen
2.3.1 Business Overview
2.3.2 NGS Based Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Qiagen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 ThermoFisher Scientific
2.4.1 Business Overview
2.4.2 NGS Based Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ThermoFisher Scientific NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Oxford Gene Technology
2.5.1 Business Overview
2.5.2 NGS Based Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Oxford Gene Technology NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Illumina
2.6.1 Business Overview
2.6.2 NGS Based Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Illumina NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pacific Biosciences
2.7.1 Business Overview
2.7.2 NGS Based Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pacific Biosciences NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Paradigm Diagnostics
2.8.1 Business Overview
2.8.2 NGS Based Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Paradigm Diagnostics NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Innogene Kalbiotech
2.9.1 Business Overview
2.9.2 NGS Based Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Innogene Kalbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Admera Health
2.10.1 Business Overview
2.10.2 NGS Based Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Admera Health NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.11 AITbiotech
2.11.1 Business Overview
2.11.2 NGS Based Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 AITbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Centogene
2.12.1 Business Overview
2.12.2 NGS Based Diagnostics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Centogene NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.13 Phalanx Biotech Group
2.13.1 Business Overview
2.13.2 NGS Based Diagnostics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Phalanx Biotech Group NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.14 iGenomX
2.14.1 Business Overview
2.14.2 NGS Based Diagnostics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 iGenomX NGS Based Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global NGS Based Diagnostics Market Competition, by Players
3.1 Global NGS Based Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 NGS Based Diagnostics Players Market Share
3.2.2 Top 10 NGS Based Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global NGS Based Diagnostics Market Size by Regions
4.1 Global NGS Based Diagnostics Revenue and Market Share by Regions
4.2 North America NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
5 North America NGS Based Diagnostics Revenue by Countries
5.1 North America NGS Based Diagnostics Revenue by Countries (2013-2018)
5.2 USA NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe NGS Based Diagnostics Revenue by Countries
6.1 Europe NGS Based Diagnostics Revenue by Countries (2013-2018)
6.2 Germany NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific NGS Based Diagnostics Revenue by Countries
7.1 Asia-Pacific NGS Based Diagnostics Revenue by Countries (2013-2018)
7.2 China NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
8 South America NGS Based Diagnostics Revenue by Countries
8.1 South America NGS Based Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue NGS Based Diagnostics by Countries
9.1 Middle East and Africa NGS Based Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa NGS Based Diagnostics Revenue and Growth Rate (2013-2018)
10 Global NGS Based Diagnostics Market Segment by Type
10.1 Global NGS Based Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global NGS Based Diagnostics Market Forecast by Type (2018-2023)
10.3 DNA Sequencing Revenue Growth Rate (2013-2023)
10.4 RNA Sequencing Revenue Growth Rate (2013-2023)
10.5 Whole Genome Sequencing Revenue Growth Rate (2013-2023)
10.6 Whole Exome Sequencing Revenue Growth Rate (2013-2023)
10.7 Other Revenue Growth Rate (2013-2023)
11 Global NGS Based Diagnostics Market Segment by Application
11.1 Global NGS Based Diagnostics Revenue Market Share by Application (2013-2018)
11.2 NGS Based Diagnostics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Academics/Research Institutions Revenue Growth (2013-2018)
12 Global NGS Based Diagnostics Market Size Forecast (2018-2023)
12.1 Global NGS Based Diagnostics Market Size Forecast (2018-2023)
12.2 Global NGS Based Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America NGS Based Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe NGS Based Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific NGS Based Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America NGS Based Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa NGS Based Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure NGS Based Diagnostics Picture
Table Product Specifications of NGS Based Diagnostics
Table Global NGS Based Diagnostics and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
